MainBoardListed
Nephrocare Health Services Limited
Company websiteNephrocare Health Services Limited is going public with an issue of ₹1,89,35,819 crore. The fresh portion of ₹76,82,717 crore typically funds growth or debt reduction.
The OFS of ₹1,12,53,102 crore provides liquidity to selling shareholders. Apply between 10-12-2025 and 12-12-2025; allotment expected on 15-12-2025.
Start Date10-12-2025
End Date12-12-2025
Listing Date17-12-2025
Allotment Date15-12-2025
Current Price₹491.70
GMP₹36 (7.83%)
Lot Size32 Shares
Subscription14.08 Times
Face Value₹2 Per Share
Listing atNSE, BSE
Issue Price₹438 - ₹460
Pre Issue₹9,26,50,799
Post Issue₹10,03,33,516
Issue Size₹1,89,35,819
(aggregating up to 871.05 Cr)
(aggregating up to 871.05 Cr)
Fresh Issue₹76,82,717
(aggregating up to 353.40 Cr)
(aggregating up to 353.40 Cr)
Offer For Sale₹1,12,53,102
(aggregating up to 517.64 Cr)
(aggregating up to 517.64 Cr)
The Grey Market Premium (GMP) for Nephrocare Health Services Limited is currently around ₹36 (7.83%). This indicates an estimated listing price of approximately ₹474 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
16 Dec 2025, 04:43 | ₹460 | ₹36 | ₹496 (7.83%) |
15 Dec 2025, 16:45 | ₹460 | ₹41 | ₹501 (8.91%) |
16 Dec 2025, 04:31 | ₹460 | ₹43 | ₹503 (9.35%) |
14 Dec 2025, 15:45 | ₹460 | ₹35 | ₹495 (7.61%) |
15 Dec 2025, 16:21 | ₹460 | ₹34 | ₹494 (7.39%) |
15 Dec 2025, 16:21 | ₹460 | ₹30 | ₹490 (6.52%) |
14 Dec 2025, 12:49 | ₹460 | ₹32 | ₹492 (6.96%) |
13 Dec 2025, 11:20 | ₹460 | ₹37 | ₹497 (8.04%) |
12 Dec 2025, 12:22 | ₹460 | ₹22 | ₹482 (4.78%) |
12 Dec 2025, 12:49 | ₹460 | ₹25 | ₹485 (5.43%) |
12 Dec 2025, 15:33 | ₹460 | ₹31 | ₹491 (6.74%) |
11 Dec 2025, 11:46 | ₹460 | ₹17.50 | ₹477.50 (3.80%) |
10 Dec 2025, 11:33 | ₹460 | ₹0 | ₹460 (0.00%) |
09 Dec 2025, 09:51 | ₹460 | ₹0 | ₹460 (0.00%) |
08 Dec 2025, 11:01 | ₹460 | ₹0 | ₹460 (0.00%) |
06 Dec 2025, 09:25 | ₹460 | ₹0 | ₹460 (0.00%) |
05 Dec 2025, 09:18 | ₹460 | ₹0 | ₹460 (0.00%) |
04 Dec 2025, 12:08 | ₹460 | ₹0 | ₹460 (0.00%) |
03 Dec 2025, 05:18 | ₹460 | ₹0 | ₹460 (0.00%) |
Financials overview In Crores
Here is a quick look at the recent financial performance of Nephrocare Health Services Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Sep-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
EPS | 1.69 | 8.28 | 4.55 | -1.53 |
ROE | 2.19 | 13.45 | 8.76 | -3.00 |
ROCE | 11.99 | 18.67 | 10.00 | 0.44 |
RONW | 0 | 0 | 0 | 0 |
PRE IPO(PE) | 0 | 63.52 | 0 | 0 |
POST IPO(PE) | 162.19 | 0 | 0 | 0 |
Subscription Details (No. of Shares)
The below shows how many shares were subscribed by each investor category in the Nephrocare Health Services Limited IPO. These numbers help you understand where the demand is coming from – whether it’s retail investors, QIBs, or NIBs. Higher subscription usually indicates strong interest and confidence from the market.
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹173.34 | 4649.18 | 26.82 |
FIIs | ₹0 | 1237.5 | 0.00 |
FIs | ₹0 | 880.28 | 0.00 |
Mutual Funds | ₹0 | 882.04 | 0.00 |
Others | ₹0 | 1649.35 | 0.00 |
RETAIL | ₹303.52 | 714.76 | 2.35 |
HNIs 2+ | ₹43.36 | 583.57 | 13.46 |
HNIs 10+ | ₹86.72 | 2638.84 | 30.43 |
EMPLOYEES | ₹3.84 | 10.82 | 2.82 |
Total | ₹610.78 | 8597.17 | 14.08 |
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
RETAIL | 2,06,197 | 4,01,889 | 1.95 |
EMPLOYEES | 0 | 3,820 | 0.00 |
HNIs(10L +) | 4,208 | 25,725 | 6.11 |
HNIs (2-10L) | 2,104 | 27,685 | 13.16 |
Total | 2,12,509 | 4,55,299 | 2.14 |
The IPO reservation for Nephrocare Health Services Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Anchor | 29.88% | 56,57,919 |
QIB | 19.90% | 37,68,224 |
HNI | 14.93% | 28,27,843 |
RETAIL | 34.85% | 65,98,301 |
Employee | 0.44% | 83,532 |
TOTAL | 100.00% | 1,89,35,819 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 32 | ₹14,720 | |
sHNI | 14 | 448 | ₹2,06,080 | |
bHNI | 68 | 2,176 | ₹10,00,960 |
Below you can find the official contact details of Nephrocare Health Services Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs@nephroplus.com
Phone: +91 40 4240 8039
Website: http://www.nephroplus.com/
Address: 5 th Floor, D Block, iLabs Centre, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad, Telangana, 500081
IPO Registrar
Name: Kfin Technologies Limited
Phone: +914067162222
Email: nephrocare.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/